Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. TEM
TEM logo

TEM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TEM News

Tempus AI Shares Approach 1-Year Low as Cathie Wood’s ARK Increases Holdings While Selling Nvidia, Meta, and Other Tech Stocks

3d agostocktwits

Tempus AI (TEM.US) Executive Plans to Sell $7.77 Million in Common Stock via Form 144

4d agomoomoo

Cathie Wood's ARK Divests Meta Shares to Invest in This AI Stock.

4d agoBarron's

Cathie Wood's ARK Divests Meta Shares to Invest in This AI Stock.

4d agoBarron's

TEMPUS AI STOCK RISES 2% IN PREMARKET TRADING FOLLOWING COLLABORATION WITH DAIICHI SANKYO ON CANCER TREATMENT

5d agomoomoo

AI Drug Discovery Efficiency Boost

Mar 21 2026NASDAQ.COM

The Future of Drug Discovery Driven by AI

Mar 21 2026Fool

Analysis of ARKK ETF's 52-Week Price Fluctuations

Mar 19 2026NASDAQ.COM

Tempus Partners with Blood Cancer United to Develop Pediatric Leukemia Registry

Mar 17 2026Newsfilter

Tempus AI Shares Rise as Analyst Reiterates Buy Rating

Mar 11 2026Benzinga

Tempus AI Study Advances Precision Medicine with Genomic Profiling

Mar 11 2026Newsfilter

Tempus AI Partners with Merck for AI-Driven Precision Medicine

Mar 03 2026Benzinga

VentriPoint Partners with LG Consulting for VMS+ Deployment

Mar 03 2026PRnewswire

VentriPoint Partners with LG Consulting for VMS+ Deployment

Mar 03 2026Newsfilter

Tempus and Merck Expand Collaboration to Advance Precision Medicine

Mar 03 2026Newsfilter

TEMPUS AI INC AND MERCK UNVEIL LONG-TERM PARTNERSHIP

Mar 03 2026moomoo